Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients [Phase 2, Phase 3]
Phase 2/3 trial updates on sitafloxacin and ertapenem for acute urinary tract infections due to E. coli or Klebsiella in post-kidney transpl…
-
FDA approval · 2023-03-02FDA Approved: NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — Supplemental Application (Alvogen Inc.)
FDA approved a supplemental application for nitrofurantoin monohydrate/macrocrystalline from Alvogen Inc., granting approval for the request…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants. [Phase 1]
A Phase 1 safety, tolerability, and pharmacokinetic study of GSK3882347 in healthy participants has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia [Phase 4]
Phase 4 trial update on shortening antibiotic treatment to 5 days for Gram-negative bacteremia and urinary tract infection due to bacterial …
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Modified Reporting From Indwelling Catheters [NA]
A completed clinical trial update regarding modified reporting from indwelling catheters for urinary tract infections.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-11-02FDA Approved: AMOXICILLIN — Supplemental Application (USAntibiotics, LLC)
FDA approved a supplemental application for Amoxicillin submitted by USAntibiotics, LLC.
-
FDA label_change · 2022-09-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for amoxicillin and clavulanate potassium submitted by Northstar RxLLC, resulting in updated labelin…
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Ertapenem Administered Subcutaneously Versus Intravenously [Phase 3]
Phase 3 trial comparing subcutaneous versus intravenous administration of ertapenem for urinary tract infections was terminated.
-
CLINICAL_TRIALS withdrawal · 2022-07-08Clinical Trial Update: Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention [Phase 4]
Phase 4 trial of methenamine for non-antibiotic, multimodal UTI prevention has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Temocillin Pharmacokinetics in Paediatrics [Phase 4]
Phase 4 clinical trial update studying temocillin pharmacokinetics in paediatric patients with infection and liver dysfunction.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: Isotonic Versus Hypotonic Fluid for Maintenance IV Therapy [Phase 3]
Phase 3 trial comparing isotonic vs hypotonic maintenance IV fluids; study completed.
-
FDA approval · 2022-03-18FDA Approved: CEFEPIME HYDROCHLORIDE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Cefepime hydrochloride and dextrose from B. Braun Medical Inc.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli [Phase 1]
Phase 1 trial update on safety, tolerability, and pharmacokinetics of LBP-EC01 in patients with urinary tract colonization by E. coli; compl…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care [Phase 3]
Phase 3 clinical trial update for extended use of fosfomycin to treat cystitis in primary care has been terminated.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Short-course Methenamine Hippurate for Prevention of Post-operative UTI [NA]
A completed clinical trial evaluating short-course methenamine hippurate for prevention of post-operative urinary tract infections and cathe…
-
FDA approval · 2022-02-18FDA Approved: NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved Jubilant Cadista Pharmaceuticals' generic nitrofurantoin monohydrate/macrocrystals (ANDA) as a bioequivalent generic product.
-
FDA approval · 2022-02-08FDA Approved: NITROFURANTOIN MACROCRYSTALS — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental application for Nitrofurantoin Macrocrystals from Zydus Pharmaceuticals (USA) Inc., updating an aspect of th…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Nutraceutical Efficacy for rUTI [Phase 2, Phase 3]
Phase 2/3 clinical trial investigating a nutraceutical for urinary tract infections was terminated; results posted in 2022.
-
FDA approval · 2022-01-26FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Cipla USA Inc.)
FDA approved the original application for fosfomycin tromethamine, a generic antibiotic, manufactured by Cipla USA Inc.
-
FDA approval · 2021-12-28FDA Approved: METHENAMINE HIPPURATE — Supplemental Application (Esjay Pharma LLC)
The FDA approved a supplemental application for Methenamine Hippurate submitted by Esjay Pharma LLC. The snippet confirms an approved supple…
-
CLINICAL_TRIALS trial_result · 2021-12-14Clinical Trial Update: Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis [Phase 4]
Phase 4 trial assessing methenamine and methylthioninium for recurrent cystitis (urinary tract infections) has been completed.
-
FDA approval · 2021-10-21FDA Approved: FOSFOMYCIN TROMETHAMINE — Original Application (Kesin Pharma Corporation)
The FDA approved Kesin Pharma Corporation's original ANDA for fosfomycin tromethamine, authorizing the marketing of a generic antibiotic.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder [Phase 1, Phase 2]
Clinical trial update exploring whether probiotics can prevent recurrent urinary tract infections in pediatric patients with neurogenic blad…
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospital [Phase 2]
Phase 2 trial updating administration of antibiotic prophylaxis for transperineal prostate biopsy at Cipto Mangunkusumo Hospital.
-
CLINICAL_TRIALS withdrawal · 2021-06-30Clinical Trial Update: Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women [Phase 3]
Phase 3 clinical trial for preventive intravaginal prasterone in postmenopausal women with recurrent UTIs was withdrawn.